Literature DB >> 24783022

Functional TSH Receptors, Malignant Melanomas and Subclinical Hypothyroidism.

Horea Ioan Ursu1.   

Abstract

Entities:  

Year:  2012        PMID： 24783022      PMCID： PMC3821473          DOI： 10.1159/000339817

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN： 2235-0640


× No keyword cloud information.
  3 in total

1.  Management of subclinical hypothyroidism: the thyroidologists' view.

Authors:  Simon H S Pearce; Mario Vaisman; Jean-Louis Wemeau
Journal:  Eur Thyroid J       Date:  2012-02-29

2.  Human melanoma cells express functional receptors for thyroid-stimulating hormone.

Authors:  Julie A Ellerhorst; Aresu Sendi-Naderi; Marilyn K Johnson; Carolyn P Cooke; Shyam M Dang; A Hafeez Diwan
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

3.  High prevalence of hypothyroidism among patients with cutaneous melanoma.

Authors:  Julie A Ellerhorst; Catherine D Cooksley; Lyle Broemeling; Marcella M Johnson; Elizabeth A Grimm
Journal:  Oncol Rep       Date:  2003 Sep-Oct       Impact factor: 3.906
  3 in total
  2 in total

Review 1.  Recognition of Melanocytes in Immuno-Neuroendocrinology and Circadian Rhythms: Beyond the Conventional Melanin Synthesis.

Authors:  Yan-Yan Chen; Li-Ping Liu; Hang Zhou; Yun-Wen Zheng; Yu-Mei Li
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 2.  Is Melanoma Progression Affected by Thyroid Diseases?

Authors:  Salvatore Ulisse; Enke Baldini; Daniele Pironi; Federica Gagliardi; Domenico Tripodi; Augusto Lauro; Sabino Carbotta; Danilo Tarroni; Matteo D'Armiento; Aldo Morrone; Flavio Forte; Flaminia Frattaroli; Severino Persechino; Teresa Odorisio; Vito D'Andrea; Eleonora Lori; Salvatore Sorrenti
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.